the role of n-acetylcysteine treatment on anti-oxidative status in patients with type ii diabetes mellitus

Creative Commons License

Ozkilic A. Ç. , Cengiz M. , Ozaydin A. , Kanigur G. , Cobanoglu A.

Journal of Basic and Clinical Physiology and Pharmacology, cilt.17, ss.245-254, 2006 (Diğer Kurumların Hakemli Dergileri)

  • Cilt numarası: 17
  • Basım Tarihi: 2006
  • Doi Numarası: 10.1515/jbcpp.2006.17.4.245
  • Dergi Adı: Journal of Basic and Clinical Physiology and Pharmacology
  • Sayfa Sayısı: ss.245-254


The development of diabetic complications has usually been attributed to the nonenzymic glycation of tissue proteins. Only recently, however, have researchers examined the possible role on free radicals in the pathogenesis of diabetes. In the present study, glutathione (GSH) and major anti oxidant enzyme levels in plasma of patients with type II diabetes mellitus were assessed both before and after 3 months of N-acetylcysteine (NAC) therapy. Thirty-two diabetic patients were examined as well as fifteen healthy controls. Before treatment with NAC, glutathione peroxidase (GPx), catalase (CAT), and (GSH) levels of diabetic patients and control subjects showed no significant differences, whereas glutathione S-transferase (GST) levels were higher in type II diabetic patients. Following 3 months of Following NAC supplementation, GSH, GST, and CAT levels were found to be similar to the levels before treatment. On the other hand, GPx activity was significantly lower compared with the values before treatment. According to this finding, NAC treatment could have a positive effect on GPx values in type II diabetic patients showing abnormally high values. © 2006, by Walter de Gruyter GmbH & Co. All rights reserved.